Polymorphic Forms of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Heat-sensitive recording materials using N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide as a colour developer face fluctuations in application-related properties due to variations in synthesis conditions, necessitating the identification and optimization of polymorphic forms to ensure consistent performance, especially in industrial-scale production.

Innovation Solution

Development of new monophase polymorphic forms, ω18.9 and α21.2, of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide, characterized by specific x-ray powder diffractograms and melting ranges, which are produced through recrystallization and suspension methods in various solvents, and their use in heat-sensitive recording materials to maintain sensitivity and performance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional synthesis conditions are used to produce N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide, then production cost and time are reduced, but fluctuations in application-related properties occur due to variations in synthesis conditions

Engineering Contradiction:
Improveconsistency of application-related propertiesVSAvoidcontrol over crystal structure
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by systematically varying crystallization conditions including solvent type (water, ethanol, isopropanol, acetonitrile, toluene, xylene), temperature ranges (0°C to reflux), and pH conditions to transform the compound into distinct polymorphic forms with specific XRD patterns. This resolves the contradiction by providing controlled parameters that ensure reliable, consistent crystal structures free from synthesis-condition variations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent utilizes phase transitions during crystallization processes, where the compound transitions from solution phase to solid crystalline phase under controlled conditions. By controlling cooling rates, solvent evaporation, and temperature profiles, the patent achieves reproducible polymorphic forms (Forms A, B, C, D, E, F, G, H) with distinct XRD characteristics, thereby ensuring reliability while maintaining manufacturing precision.

Inventive Principle:
Principle #36Phase transitions

2Temperature

If polymorphic forms are optimized to improve static sensitivity (higher starting temperature), then static sensitivity is improved, but dynamic sensitivity may be compromised

Engineering Contradiction:
Improvestarting temperature of colour-forming reactionVSAvoiddynamic response sensitivity
Core Design Contradiction:
TemperatureVSReliability

Solution Approach 1:

The patent applies local quality by optimizing specific regions of the temperature-response curve for different polymorphic forms. Each polymorphic form (A-H) is characterized by its specific melting point range and XRD pattern, allowing selection of the appropriate form based on whether the application prioritizes higher starting temperature (static sensitivity) or faster response at operating temperature (dynamic sensitivity). This resolves the contradiction by enabling form-specific optimization rather than compromising overall performance.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new polymorphic forms provide improved static sensitivity and maintain dynamic sensitivity, allowing for higher starting temperatures of the colour-forming reaction without compromising print quality, thus enhancing the reliability and efficiency of heat-sensitive recording materials.

Implementation Method 1

Development of new monophase polymorphic forms, ω18.9 and α21.2, of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide, characterized by specific x-ray powder diffractograms and melting ranges, which are produced through recrystallization and suspension methods in various solvents

Methodology Applied
Scientific EffectCrystallisation: Crystallisation

Implementation Method 2

characterized by specific x-ray powder diffractograms and melting ranges

Methodology Applied
Scientific EffectMelting: Melting

Data Source

PatentUS11673859B2Polymorphic forms of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzolsulfonamide
Publication Date: 2023.06.13 KOEHLER PAPER SE
  • US11673859B2 patent drawing
  • US11673859B2 patent drawing

AI summary

The present invention relates to an N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide in the polymorphic form ω18.9, characterised by an x-ray powder diffractogram having the Bragg angles (2θ/CuKα) 10.9, 11.7, 14.6, 15.0, 15.8, 16.6, 17.6, 18.9, 19.4, 20.9, 21.2, 22.0, 23.3, 24.4, 24.7, 26.1, 27.4, 29.4, 34.2,or in the polymorphic form α21.2, characterised by an x-ray powder diffractogram having the Bragg angles (2θ/CuKα) 8.7, 9.8, 10.8, 13.2, 13.9, 14.9, 15.2, 16.0, 17.4, 17.7, 18.7, 20.4, 21.2, 21.6, 22.3, 23.0, 23.3, 23.9, 24.4, 25.0, 25.8, 26.6, 28.1, 28.9, 29.4, 30.1, 30.6, 31.8, 34.5, 35.3, 35.6, 36.9, a method for production thereof, use thereof as a colour developer in a heat-sensitive recording material, and a heat-sensitive recording material comprising N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzenesulfonamide in the polymorphic form ω18.9 or in the polymorphic form α21.2.